78 related articles for article (PubMed ID: 3402902)
1. Effects of verapamil on estimated hepatic blood flow in patients with HBsAg-positive cirrhosis.
Lay CS; Tsai YT; Kong CW; Lee FY; Lee SD; Chen KY; Chiang BN; Lo KJ
Hepatogastroenterology; 1988 Jun; 35(3):121-4. PubMed ID: 3402902
[TBL] [Abstract][Full Text] [Related]
2. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis.
Sugano S; Kawafune T; Suzuki T; Kubota M; Okajima T; Sumino Y; Akita H
Am J Gastroenterol; 1995 May; 90(5):788-93. PubMed ID: 7733089
[TBL] [Abstract][Full Text] [Related]
4. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K
Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
[TBL] [Abstract][Full Text] [Related]
5. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension.
Albillos A; Lledó JL; Bañares R; Rossi I; Iborra J; Calleja JL; Garrido A; Escartin P; Bosch J
Hepatology; 1994 Sep; 20(3):611-7. PubMed ID: 7915703
[TBL] [Abstract][Full Text] [Related]
7. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis.
Kakumitsu S; Shijo H; Yokoyama M; Kim T; Akiyoshi N; Ota K; Kubara K; Okumura M; Inoue K
Hepatology; 1998 Feb; 27(2):377-82. PubMed ID: 9462634
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
[TBL] [Abstract][Full Text] [Related]
9. Extraction of 125I-albumin microaggregates from portal blood. An index of functional portal blood supply in cirrhotics.
Huet PM; Marleau D; Lavoie P; Viallet A
Gastroenterology; 1976 Jan; 70(1):74-81. PubMed ID: 1245287
[TBL] [Abstract][Full Text] [Related]
10. [Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].
Nomura F; Ohnishi K; Ohto M; Takeda Y; Rikihisa T; Kanakubo Y
Rinsho Byori; 1991 Oct; 39(10):1093-7. PubMed ID: 1762184
[TBL] [Abstract][Full Text] [Related]
11. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension.
Navasa M; Bosch J; Reichen J; Bru C; Mastai R; Zysset T; Silva G; Chesta J; Rodés J
Hepatology; 1988; 8(4):850-4. PubMed ID: 3391511
[TBL] [Abstract][Full Text] [Related]
12. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
Feu F; Bordas JM; Luca A; García-Pagán JC; Escorsell A; Bosch J; Rodés J
Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
14. Lack of effects of nifedipine on hepatic hemodynamics in patients with HBsAg-positive cirrhosis.
Lay CS; Tsai YT; Kong CW; Lee FY; Lee SD; Lo KJ; Chiang BN; Chen KY
Liver; 1987 Aug; 7(4):223-7. PubMed ID: 3683094
[TBL] [Abstract][Full Text] [Related]
15. Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites.
Okumura H; Aramaki T; Katsuta Y; Satomura K; Akaike M; Sekiyama T; Terada H; Ohsuga M; Komeichi H; Tsutsui H
Am J Gastroenterol; 1991 Jan; 86(1):46-52. PubMed ID: 1986554
[TBL] [Abstract][Full Text] [Related]
16. Hepatic arterial buffer response in patients with advanced cirrhosis.
Gülberg V; Haag K; Rössle M; Gerbes AL
Hepatology; 2002 Mar; 35(3):630-4. PubMed ID: 11870377
[TBL] [Abstract][Full Text] [Related]
17. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis.
Tsai YT; Lee FY; Lin HC; Chang TT; Lay CS; Wang SS; Kong CW; Lee SD; Lo KJ
Hepatology; 1989 Sep; 10(3):283-7. PubMed ID: 2759546
[TBL] [Abstract][Full Text] [Related]
18. The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites.
Lay CS; Tsai YT; Kong CW; Lee FY; Chang TT; Lin HC; Yang CM; Lee SD; Chiang BN; Lo KJ
Clin Pharmacol Ther; 1988 Oct; 44(4):453-7. PubMed ID: 3168396
[TBL] [Abstract][Full Text] [Related]
19. Verapamil pharmacokinetics and liver function in patients with cirrhosis.
Finucci GF; Padrini R; Piovan D; Melica E; Merkel C; Gatta A; Zuin R
Int J Clin Pharmacol Res; 1988; 8(2):123-6. PubMed ID: 3378854
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
Braillon A; Calès P; Lebrec D
Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]